Inozyme Pharma, Inc.

Insider Reports History

Location
Boston, MA
Signature
/s/ Axel Bolte, as attorney-in-fact for Sarah Bhagat
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Inozyme Pharma, Inc.:

Form 4 holding Director

Inozyme Pharma, Inc.

Security class
Stock Option (right to buy)
Shares / value
9,367
Estimated value
Report date
23 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Inozyme Pharma, Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .